Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease

Abstract

Sodium-butyrate supplementation increases the growth of bacteria able to produce SCFA with potentially anti-inflammatory action. The clinical impact of this finding requires further investigation.